Market Overview

Neoprobe Names Executive VP, Chief Business Officer


Neoprobe Corporation (NYSE: NEOP) announced today that Thomas Tulip, Ph.D., has joined the company as Executive Vice President and Chief Business Officer. Dr. Tulip has spent more than 25 years in the development and commercialization of radiopharmaceuticals and imaging agents, with a track record of success in R&D, business development, brand and alliance management as well as international business.

Posted-In: News Management


Related Articles (NEOP)

View Comments and Join the Discussion!

Get Benzinga's Newsletters